Company page

Vaxcyte, Inc.

Vaxcyte, Inc. is a public company traded under the ticker PCVX in the American market. The company has a market capitalization of approximately $7.89 billion. Vaxcyte focuses on developing innovative vaccines to address various infectious diseases.